876 studies found for:    Open Studies | "Prostatic Diseases"
Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Rank Status Study
1 Recruiting Clinical Trial of Prostatic Arterial Embolization Versus a Sham Procedure to Treat Benign Prostatic Hyperplasia
Conditions: Prostatic Hyperplasia, Benign;   Prostatic Hypertrophy, Benign;   Genital Diseases, Male;   Lower Urinary Tract Symptoms;   Prostatic Diseases
Interventions: Procedure: Prostatic Arterial Embolization;   Procedure: Sham procedure
2 Recruiting MRI for Assessment of Hypoxia-Induced Prostate Cancer Aggressiveness
Conditions: Prostatic Neoplasms;   Genital Neoplasms, Male;   Prostatic Diseases
Intervention:
3 Not yet recruiting A Prospective Trial of Povidone-iodine Suppository Before Transrectal Ultrasound Guided Prostate Biopsy
Conditions: Infection;   Prostatic Diseases;   Misadventure During Aspirating Needle Biopsy
Intervention: Drug: Povidone-Iodine
4 Recruiting Molecular Studies and Clinical Correlations in Human Prostatic Disease
Condition: Prostate Cancer
Intervention:
5 Recruiting Phase 1-2 Study of Onapristone in Patients With Advanced Castration-resistant Prostate Cancer
Conditions: Prostate Cancer;   Metastatic Prostate Cancer;   Androgen-independent Prostate Cancer;   Recurrent Prostate Cancer
Intervention: Drug: onapristone
6 Recruiting Radiotherapy vs Observation for CRPC
Condition: Hormone Refractory Prostate Cancer
Intervention:
7 Unknown  Efficacy and Safety Study of the Therapeutic Vaccine PEP223 in Prostate Cancer Patients
Condition: Prostate Cancer
Intervention: Biological: PEP-223/CoVaccine HT
8 Recruiting Fuse Image MRI Guided Prostate Cryotherapy
Conditions: Neoplasms Prostate;   Cancer of the Prostate
Intervention: Procedure: FUSE IMAGE MRI GUIDED PROSTATE CRYOTHERAPY
9 Recruiting Radiosensitizing and Radioprotectve Effects of Curcumin in Prostate Cancer
Conditions: Prostate Cancer;   Radiation Therapy
Interventions: Dietary Supplement: Curcumin;   Dietary Supplement: Placebo
10 Recruiting Cabozantinib and Androgen Ablation in Patients With Androgen-Dependent Metastatic Prostate Cancer
Condition: Prostate Cancer
Interventions: Drug: Cabozantinib;   Drug: Androgen Ablation Therapy
11 Not yet recruiting Cabazitaxel Versus the Switch to Alternative AR Targeted Therapy Enzalutamide or Abiraterone in Metastatic Castration-Resistant Prostate Cancer (mCRPC) Primary Resistant Patients to Abiraterone or Enz
Condition: Prostate Cancer Metastatic
Interventions: Drug: CABAZITAXEL XRP6258;   Drug: Enzalutamide;   Drug: Abiraterone acetate;   Drug: Prednisone
12 Recruiting Radiation Therapy With or Without Androgen-Deprivation Therapy in Treating Patients With Prostate Cancer
Condition: Prostate Cancer
Interventions: Drug: bicalutamide;   Drug: buserelin;   Drug: flutamide;   Drug: goserelin acetate;   Drug: leuprolide acetate;   Drug: triptorelin;   Radiation: 3-dimensional conformal radiation therapy;   Radiation: intensity-modulated radiation therapy
13 Recruiting Efficacy and Safety of S-Equol on Men With Benign Prostatic Hyperplasia
Condition: Benign Prostatic Hyperplasia
Interventions: Drug: S-equol;   Drug: Placebo
14 Recruiting Registry of Irreversible Electroporation for the Ablation of Prostate Cancer With Use of Nanoknife Device
Condition: Prostate Cancer
Intervention:
15 Recruiting Hypofractionated Stereotactic Body Radiation Therapy as a Boost to the Prostate
Condition: Prostate Cancer
Intervention: Radiation: CyberKnife Boost
16 Recruiting Safety and Efficacy of 0.5mg Dutasteride and 0.4mg Tamsulosin Combination Once Daily for Six Months for Benign Prostatic Hyperplasia
Condition: Prostatic Hyperplasia
Intervention: Drug: Dutasteride/Tamsulosin
17 Unknown  ZOLEDRONIC ASSOCIATED With Hight Hypofractionated Radiotherapy Dose in Bone Metastases Vertebral Prostate Adenocarcinoma
Condition: Prostate Adenocarcinoma
Interventions: Radiation: external  radiotherapy;   Drug: Acide zoledronic
18 Unknown  A Study of Epirubicin With Estramustine Phosphate and Celecoxib for the Treatment of Prostate Cancer
Condition: Prostate Cancer
Interventions: Drug: Epirubicin;   Drug: Estramustine Phosphate;   Drug: Celecoxib
19 Not yet recruiting Rilimogene-Galvacirepvec in Preventing Disease Progression in Patients With Localized Prostate Cancer Undergoing Active Surveillance
Conditions: Prostate Adenocarcinoma;   Stage I Prostate Cancer;   Stage IIA Prostate Cancer
Interventions: Other: Laboratory Biomarker Analysis;   Other: Placebo;   Biological: Rilimogene-galvacirepvec
20 Unknown  PSA Antibody Levels in Samples From Patients With Prostate Cancer Treated on Protocol ECOG-E9802
Condition: Prostate Cancer
Intervention: Other: laboratory biomarker analysis

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years